Cite
MLA Citation
Feng Wen et al.. “Patient‐based cost‐effectiveness analysis of FOLFIRI versus FOLFOX7 for advanced gastric adenocarcinoma in China: A 4‐year prospective randomised phase II study.” European journal of cancer care, vol. 29, 2020, p. n/a. http://access.bl.uk/ark:/81055/vdc_100099333734.0x000039